Quality Control Patient Care
Resume:
Sheena Soberanis, MD Hampton, GA *****
******.*********@*****.***
CAREER OBJECTIVE
I am a non practicing MD with a MS in Biotechnology. I am a detail-oriented and dedicated medical professional with a passion for advancing medicine by ways of research and development and improving overall patient care.. Leveraging my strong organizational skills, attention to detail, and experience in protocol adherence, I aim to facilitate the seamless execution of improving patient outcomes. Committed to ensuring regulatory compliance and patient safety, I strive to contribute to the development of ongoing policies that positively impact patient outcomes and support your company all while supporting the clinical team in achieving their objectives.
EXPERIENCE
PennHealth, Pennsylvania, PA — Clinical Chart/Documentation Specialist
October 2023 - March 2025
Reviewed patient charts for quality control and accuracy. Reported any errors in documentation or treatment to appropriate providing physicians. Meet turnaround time requirements for all clinical documentation. Provided revision and quality control checks for others on my team to ensure their work was within SOP for insurance documentation and reimbursement purposes.
MaxxLife Wellness, McDonough, GA — Contract Clinical Director
August 2024 - December 2024
Provided operations support for the facility. Oversee the care provided to the patients of the facility. Quality control of patient charts and medications to ensure that each patient received correct treatment plans according to proper diagnosis. Directly supervised facility staff to ensure they were compliant with all healthcare rules regulations and guidelines. Ensured all staff were up to date on quality care credentialing. Processing paperwork for STD/LTD and FMLA claims.
Infectious Disease Specialist of Atlanta, Decatur, GA — Clinical Research Coordinator
September 2021 - March 2024
Provide clinical support for clinical trial patients. Collect specimens, urine, and vitals for those patients. Schedule and confirm study visits and DEXA scans within protocol windows for study patients. Preparation of study kits to include verification of correct investigational product assignment prior to subject dispensation. Conducted study visits according to the protocol within study windows set forth by the sponsor. Communicate and conduct monitor visits SKILLS
Extensive Background and
Knowledge in Multiple
Disciplines Regarding
Medicine
Account Management and
Leadership Experience
Proficient in Microsoft Office
Effective Time Management
Clinical Management
Experience
Experience in Different
Electronic Data Capturing
Systems
Experience with Clinical Trials
Exclusion, Inclusion Criteria,
and Recruitment
Experience in Identifying and
Analyzing Public Health Issues
Experience with High Volume
Work Loads and Self
Motivation
Combat Trained Military
Veteran
TRAINING/CERTIFICATIONS
GCP (NIH)
IATA
Allscripts
EPIC
BLS
ACLS
IV Insertion
with sponsors as needed for trial oversight. Review budget, source documents, DOA, and other logs to make sure they are in line with sponsor guidelines. Handle central IRB submissions, site regulatory submissions, maintain regulatory binders, electronic data entry (including query resolution). Interface with CRO monitors at site visits (IMV and COV). Provided clinical trial support through patient inclusion, exclusion, and recruitment. Provided clinical support for an array of infectious disease processes to include HIV, TB, MDR TB,Cystic Fibrosis and other diseases.
Nissi Family Medicine, Austell, GA — Associate Provider/Chart Reviewer/Senior Office Staff
February 2019 - March 2020
Employed as an Associate Provider and medical records specialist, tasked with transcribing, translating, and meticulously reviewing patient records, charts, and data across multiple EMR systems within a family medicine/nursing home setting. Responsibilities included meticulously tracking and categorizing patient treatment plans and medication efficacy. Additionally, collaborated closely with supervising physicians to conduct comprehensive patient assessments during visits, ensuring meticulous attention to long-term condition management. Duties extended to prescribing and renewing medications, as well as facilitating referrals to specialist practitioners as necessary. Moreover, spearheaded the administration of the vaccines for children program, overseeing compliance with vaccination protocols for underprivileged children. Maintained strict adherence to vaccine integrity, monitoring temperatures and stability in accordance with manufacturer guidelines and standard operating procedures. Conducted daily reviews of temperature logs to promptly address any deviations from established parameters. Furthermore, provided interpretation of laboratory results to facilitate patient follow-up and tailored treatment recommendations accordingly. Managed the outpatient body contouring department to include sales and marketing of services.
EDUCATION
University of Medicine and Health Sciences, St.Kitts — Doctor of Medicine
August 2013 - June 2019
Johns Hopkins University, Baltimore, MD — MS Biotechnology August 2011 - June 2013
University of Mary Hardin-Baylor, Belton, TX — BS Cellular Biology/Psychology
August 2009 - June 2011
Academy of Health Sciences, Fort Sam Houston, TX — AS Surgical Technologist
November 2003 - April 2004
LANGUAGES
English
PROFESSIONAL AFFILIATIONS
American Academy of Family
Physicians
Disabled American Veterans
RESEARCH ACTIVITIES
Study Coordinator
ViiV Healthcare Company, 212483
A Phase 2b, randomized, double-blind, parallel-group study to assess the and resistance profile of GSK3640254 in combination with dolutegravir c lamivudine in HIV-1 infected, treatment-naïve adults. 2021-ongoing. ViiV Healthcare Company, 217038
Observational Cohort Study of Cabenuva Utilization, Outcomes, and Pati States (BEYOND). 2021-ongoing.
Research Assistant
ContraFect Corporation, CF-301-105
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Exebacase in Patients Receiving Standard-of-Care Antibiotics for the T aureus Bloodstream Infections (Bacteriemia), Including Right-Sided Infe 2021-ongoing.
Merck Sharp & Dohme Corp., MK-8591-013
A Phase 2b, Randomized, Active-Controlled, Double-Blind, Dose-Rangin a Switch to Islatravir (ISL) and MK-8507 Once-Weekly in Adults With H Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FT 2021-ongoing.
Merck Sharp & Dohme Corp., MK-8591A-018
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study Doravirine/Islatravir (DOR/ISL) Once-Daily in Participants With HIV- 1 Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF). 2020- Merck Sharp & Dohme Corp., MK-8591A-020
A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in H Treatment-Naïve Participants. 2020-ongoing.
ViiV Healthcare, GSK-213500
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Lo Long-acting Rilpivirine Administered Every Two Months From a Bictegr Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are V 2020-ongoing.
ViiV Healthcare, GSK-204862
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Stu Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in Are Virologically Suppressed. 2018-ongoing.
REFERENCES
Adam Bressler, MD
********@*****.***
Jeremy Osborne, MD
Marjorie Simpson, MD
Additional References Available Upon Request
Contact this candidate